Anas Barakat1,2, Aemn Ismail1, Supratik Chattopadhyay1,2, Quentin Davies1. 1. Department of Gynaecological Oncology, University Hospitals of Leicester NHS Trust, Leicester, U.K. 2. Leicester Cancer Research Centre, University of Leicester, Leicester, U.K.
Abstract
BACKGROUND/AIM: It is well established that around one-third of patients with atypical endometrial hyperplasia (AEH) go on to develop endometrial cancer (EC). PATIENTS AND METHODS: This retrospective cohort study included 119 patients recruited from the University Hospitals of Leicester from 01/01/2015 to 01/01/2020 with a diagnosis of AEH by endometrial biopsy. Patients were divided into two groups according to the management modality: Primary surgery (n=99), and conservative treatment (n=20). The aim of this study was to determine the incidence of EC in patients with AEH in University Hospitals of Leicester, UK, and to explore the reasons why patients with AEH opted for conservative management. RESULTS: EC was diagnosed in 34.4% of patients with AEH managed by primary surgery. Moreover, the incidence of EC in patients with AEH managed conservatively was 25%. The main reason for opting for conservative management was that patients were unfit for surgery when assessed in the high-risk Anaesthetic Clinic (35%). CONCLUSION: AEH is a pre-malignant lesion that has high risk of EC regardless of the mode of management. Total hysterectomy is the safest first line of treatment in AEH due to the high risk of concurrent EC and progression to EC. Currently, there is no reliable follow-up intervention to distinguish between concurrent EC and progression of AEH. Adequate discussion and counselling are essential when discussing conservative management for women with complex AEH. Patients should be counselled regarding the high risk of developing concurrent EC and risk of progression to EC. Copyright 2022, International Institute of Anticancer Research.
BACKGROUND/AIM: It is well established that around one-third of patients with atypical endometrial hyperplasia (AEH) go on to develop endometrial cancer (EC). PATIENTS AND METHODS: This retrospective cohort study included 119 patients recruited from the University Hospitals of Leicester from 01/01/2015 to 01/01/2020 with a diagnosis of AEH by endometrial biopsy. Patients were divided into two groups according to the management modality: Primary surgery (n=99), and conservative treatment (n=20). The aim of this study was to determine the incidence of EC in patients with AEH in University Hospitals of Leicester, UK, and to explore the reasons why patients with AEH opted for conservative management. RESULTS: EC was diagnosed in 34.4% of patients with AEH managed by primary surgery. Moreover, the incidence of EC in patients with AEH managed conservatively was 25%. The main reason for opting for conservative management was that patients were unfit for surgery when assessed in the high-risk Anaesthetic Clinic (35%). CONCLUSION: AEH is a pre-malignant lesion that has high risk of EC regardless of the mode of management. Total hysterectomy is the safest first line of treatment in AEH due to the high risk of concurrent EC and progression to EC. Currently, there is no reliable follow-up intervention to distinguish between concurrent EC and progression of AEH. Adequate discussion and counselling are essential when discussing conservative management for women with complex AEH. Patients should be counselled regarding the high risk of developing concurrent EC and risk of progression to EC. Copyright 2022, International Institute of Anticancer Research.
Entities:
Keywords:
Endometrial cancer; atypical endometrial hyperplasia; mode of management
Authors: Olivia Raglan; Ilkka Kalliala; Georgios Markozannes; Sofia Cividini; Marc J Gunter; Jaya Nautiyal; Hani Gabra; Evangelos Paraskevaidis; Pierre Martin-Hirsch; Kostas K Tsilidis; Maria Kyrgiou Journal: Int J Cancer Date: 2019-02-20 Impact factor: 7.396
Authors: Stephanie L Wethington; Thomas J Herzog; William M Burke; Xuming Sun; Jodi P Lerner; Sharyn N Lewin; Jason D Wright Journal: Ann Surg Oncol Date: 2011-06-24 Impact factor: 5.344
Authors: Monica Hagan Vetter; Blair Smith; Jason Benedict; Erinn M Hade; Kristin Bixel; Larry J Copeland; David E Cohn; Jeffrey M Fowler; David O'Malley; Ritu Salani; Floor J Backes Journal: Am J Obstet Gynecol Date: 2019-08-08 Impact factor: 8.661
Authors: Juan Luis Alcázar; Laura Bonilla; Julia Marucco; Ana Isabel Padilla; Enrique Chacón; Nabil Manzour; Aina Salas Journal: J Clin Ultrasound Date: 2018-08-16 Impact factor: 0.910